NO992058D0 - FremgangsmÕte for fremstilling av fysostigminkarbamatderivater fra eseretoler - Google Patents

FremgangsmÕte for fremstilling av fysostigminkarbamatderivater fra eseretoler

Info

Publication number
NO992058D0
NO992058D0 NO992058A NO992058A NO992058D0 NO 992058 D0 NO992058 D0 NO 992058D0 NO 992058 A NO992058 A NO 992058A NO 992058 A NO992058 A NO 992058A NO 992058 D0 NO992058 D0 NO 992058D0
Authority
NO
Norway
Prior art keywords
eseretols
preparation
carbamate derivatives
physostigmine carbamate
physostigmine
Prior art date
Application number
NO992058A
Other languages
English (en)
Other versions
NO992058L (no
Inventor
Thomas Bing Kin Lee
Zhongli Gao
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO992058D0 publication Critical patent/NO992058D0/no
Publication of NO992058L publication Critical patent/NO992058L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO992058A 1996-10-31 1999-04-29 FremgangsmÕte for fremstilling av fysostigminkarbamatderivater fra eseretoler NO992058L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/739,402 US5665880A (en) 1996-10-31 1996-10-31 Method of preparation of physostigmine carbamate derivatives from eseretholes
PCT/US1997/012370 WO1998018799A1 (en) 1996-10-31 1997-07-21 Method of preparation of physostigmine carbamate derivatives from eseretholes

Publications (2)

Publication Number Publication Date
NO992058D0 true NO992058D0 (no) 1999-04-29
NO992058L NO992058L (no) 1999-04-29

Family

ID=24972126

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992058A NO992058L (no) 1996-10-31 1999-04-29 FremgangsmÕte for fremstilling av fysostigminkarbamatderivater fra eseretoler

Country Status (14)

Country Link
US (2) US5665880A (no)
EP (1) EP0937080A1 (no)
JP (1) JP2001503049A (no)
KR (1) KR20000052891A (no)
CN (1) CN1235607A (no)
AR (1) AR009300A1 (no)
AU (1) AU712493B2 (no)
BR (1) BR9712719A (no)
CA (1) CA2268150A1 (no)
HU (1) HUP9904284A3 (no)
IL (1) IL129661A0 (no)
NO (1) NO992058L (no)
WO (1) WO1998018799A1 (no)
ZA (1) ZA976712B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19956920A1 (de) 1999-11-26 2001-05-31 Bayer Ag Verfahren zur Herstellung von 2-(2-Hydrodyphenyl)-2-(alkoxyimino)-N-methyl-acetamid-Derivaten
US6495700B1 (en) 2002-01-09 2002-12-17 Axonyx, Inc. Process for producing phenserine and its analog
KR20070085033A (ko) * 2003-10-21 2007-08-27 코루시드 파마슈티컬즈 인코포레이티드 콜린에스테라제를 억제하고 약리 활성제를 방출하는카르바모일 에스테르
US20050228019A1 (en) * 2004-01-26 2005-10-13 Cortex Pharmaceuticals, Inc. Enhancement of ampakine-Induced facilitation of synaptic responses by cholinesterase inhibitors
EP2125709A2 (en) * 2007-02-02 2009-12-02 Colucid Pharmaceuticals, Inc. Compounds that inhibit cholinesterase
CN101121717B (zh) * 2007-05-17 2010-07-28 四川大学 抗老年痴呆疾病的天然药物毒扁豆碱及其衍生物苯胺基甲酸酯毒扁豆酚碱的合成
SE531698C2 (sv) 2007-07-12 2009-07-07 Respiratorius Ab Nya bronkdilaterande a,b-omättade amider
US20090048229A1 (en) * 2007-07-18 2009-02-19 Rupniak Nadia M J Methods for promoting wakefulness
US8593728B2 (en) * 2009-02-19 2013-11-26 Toyota Motor Engineering & Manufacturing North America, Inc. Multilayer photonic structures

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2905054C3 (de) * 1979-02-08 1982-04-29 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 4-Hydroxyindolen
US4652635A (en) * 1983-05-02 1987-03-24 Polaroid Corporation Method for converting ether groups to hydroxyl groups and ester groups to acid groups
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US5187165A (en) * 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
US4971992A (en) * 1989-03-27 1990-11-20 Hoechst-Roussel Pharmaceuticals Inc. Carbonate derivatives of eseroline
EP0418770B1 (en) * 1989-09-19 1995-07-19 Hoechst-Roussel Pharmaceuticals Incorporated Process for the chemical resolution of 5-alkoxy-substituted (+/-)-1,3-dimethyloxindolylethylamines
US4937341A (en) * 1989-09-28 1990-06-26 Hoechst-Roussel Pharmaceuticals Inc. Process for preparing N-aminocarbarbamates related to physostigmine
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5260452A (en) * 1989-11-03 1993-11-09 Hoechst-Roussel Pharmaceuticals Inc. 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5177101A (en) * 1989-11-30 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5274117A (en) * 1990-01-22 1993-12-28 Hoechst-Roussel Pharmaceuticals, Inc. Process for the enantioselective synthesis of intermediates used in the preparation of physostigmine
US4983616A (en) * 1990-02-01 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
US5091541A (en) * 1990-02-01 1992-02-25 Hoechst-Roussel Pharmaceuticals Inc. Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
US5216017A (en) * 1990-05-11 1993-06-01 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo[2,3-b]indole-ketones and analogs
US5264587A (en) * 1990-05-17 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Method of preparing α-oxopyrrolo[2,3-b]indole acetic acids and derivatives
US5173497A (en) * 1990-05-17 1992-12-22 Hoechst-Roussel Pharmaceuticals Incorporated Alpha-oxopyrrolo[2,3-B]indole acetic acids, esters, amides and related analogs
MC2287A1 (fr) * 1990-06-27 1993-07-14 Hoechst Roussel Pharma Tetrahydroisoquinoleinylcarbamates de 1,2,3,3a,8,8a-hexahydro-1,31,8-trimethylpyrrolo(2,3,-b)indole
US5234941A (en) * 1991-10-01 1993-08-10 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
US5231093A (en) * 1991-10-01 1993-07-27 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
US5153193A (en) * 1991-10-01 1992-10-06 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
PH30885A (en) * 1992-07-21 1997-12-23 Hoechst Roussel Pharma Preparation of physostigmie carbamate derivatives from physostigmine.
US5302721A (en) * 1992-07-21 1994-04-12 Hoechst-Roussel Pharmaceuticals Incorporated Method of preparation of physostigmine carbamate derivatives from eseretholes
US5350762A (en) * 1993-03-08 1994-09-27 Hoechst-Roussel Pharmaceuticals Incorporated Tetrahydrocyclopent[B]indole methanamines and related compounds

Also Published As

Publication number Publication date
HUP9904284A3 (en) 2000-09-28
ZA976712B (en) 1998-04-30
JP2001503049A (ja) 2001-03-06
KR20000052891A (ko) 2000-08-25
US5665880A (en) 1997-09-09
AU3801097A (en) 1998-05-22
AU712493B2 (en) 1999-11-11
CN1235607A (zh) 1999-11-17
NO992058L (no) 1999-04-29
EP0937080A1 (en) 1999-08-25
IL129661A0 (en) 2000-02-29
AR009300A1 (es) 2000-04-12
WO1998018799A1 (en) 1998-05-07
US5734062A (en) 1998-03-31
CA2268150A1 (en) 1998-05-07
BR9712719A (pt) 1999-10-26
HUP9904284A2 (hu) 2000-05-28

Similar Documents

Publication Publication Date Title
NO20002443L (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
NO941173D0 (no) Fremgangsmåte for opparbeiding av residue fra organoklorsilansyntese
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO20002174D0 (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO992058D0 (no) FremgangsmÕte for fremstilling av fysostigminkarbamatderivater fra eseretoler
NO20001387D0 (no) Fremgangsmåte for syntese av kinolinderivater
NO932615D0 (no) Fremgangsmaate for fremstilling av physotigmin-karbonat-derivater fra esteretoler
NO20024058L (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
NO993011D0 (no) FremgangsmÕte for fremstilling av fysostigminkarbamatderivater fra eserolinethere
NO963187D0 (no) Fremgangsmåte for syntese av gamma-pyroner
NO955082L (no) Fremgangsmåte for fremstilling av glutardialdehyd
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO932616D0 (no) Fremgangsmaate for fremstilling av fysostigminkarbonatderivater fra fysostigmin
NO973835L (no) Fremgangsmåte for fremstilling av lorakarbefmonohydrat
NO981467L (no) FremgangsmÕte for fremstilling av etere fra alkoholer
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20013044L (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO962809D0 (no) Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO953459D0 (no) Fremgangsmåte ved fremstilling av cykloheptimidazolderivater
FI974027A0 (fi) Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi eseretoleista
NO991098D0 (no) FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application